PLU-1 is a novel breast cancer associated nuclear protein containing highly conserved domains including the PLU domain, putative DNA/ chromatin binding motifs, and PHD/LAP domains. Here we report the cloning of the mouse homologue (Plu-1), and document its expression in adult tissues, mammary tumours and the embryo. The overall homology with human PLU-1 is 94% at the protein level, with almost 100% identity in the conserved domains, suggesting functional conservation. As with human PLU-1 the expression of Plu-1 in adult tissues is restricted, with high expression being seen only in testis, while expression in mammary tumours from c-neu transgenic mice is high. Plu-1 is also differentially expressed in the adult mammary gland. In the developing embryo Plu-1 is expressed in a temporally restricted fashion with tissue specific expression being limited to parts of the developing brain, whisker follicle, mammary bud, thymus, limbs, intervertebral disc, olfactory epithelium, teeth, eye, and stomach. The temporal and spatial expression patterns of the transcription factors Bf-1 and Pax9, recently found to bind to PLU-1 through the PLU domain overlap with Plu-1 expression during development. Thus Plu-1 appears to play an important role in mouse embryonic development which may involve interaction with Pax9 and Bf-1. q
Results and discussion

Mouse Plu-1 cDNA
The full-length Plu-1 cDNA was isolated from a mouse mammary carcinoma cell line (410.4) using RT-PCR with primers generated from EST sequences (accession number for 3 0 AI022884 and for 5 0 AI430663) giving a 4750 bp product. 5 0 and 3 0 RACE identified a single transcriptional start site and two transcripts with different 3 0 untranslated regions giving rise to cDNA sequences of 6490 and 5372 nucleotides, respectively. The sequence of the predicted Plu-1 protein shares 94% homology with the sequence of human PLU-1. Plu-1 is a member of a gene family coding for proteins containing the novel PLU motif (Lu et al., 1999; QuadbeckSeeger et al., 2000) as well as PHD domains (Balciunas, 2000) , and a DNA binding domain originally defined by the dead ringer protein (dri) in Drosophila (Gregory et al., 1996, Fig. 1) . The sequences in these domains are almost 100% conserved in PLU-1 and mouse Plu-1.
1.2. Expression of Plu-1 in adult tissue, in the differentiating mammary gland and in mammary tumours Fig. 2A shows the expression of Plu-1 mRNA in normal adult tissues and in the embryo using a dot blot. The Plu-1 expression level was normalised against the ubiquitin mRNA level (data not shown) and, as previously found for the human PLU-1 (Barrett et al., 2002; Lu et al., 1999) , high expression of mouse Plu-1 in normal adult tissues is limited to testis (Plu-1/ubiqutin ration: 14) with moderate expression being seen in the eye, prostate, and ovary (Plu-1/ubiqutin ration: 1.3, 1.3 and 1.1, respectively). For all other tissues the Plu-1/ubiqutin ratio was below 1.
The invaginating epithelium in the mammary bud in day 14.5 embryos shows strong expression of Plu-1 mRNA (Fig.  3cD , E) in contrast to the ductal epithelial cells of the adult virgin mammary gland where Plu-1 expression is very low (Fig. 3cF, G) . However, Northern blot analysis shows that expression increases in the second half of pregnancy when the alveolar buds progressively develop into individual alveoli (Fig. 3a) . Thereafter, expression decreases at lactation and is marginal at the beginning of involution. Using a PLU-1/Plu-1 specific antiserum (Barrett et al., 2002) this Fig. 1 . Domain structure of Plu-1 compared with other proteins containing PLU, ARID or PHD domains. PHD domains are numbered 1, 2, or 3. Jumonji has no PHD domain, but has a C5HC2 finger in an equivalent position which is shown by a numbered box as for the PHD domains. Protein details: PLU-1 (Lu et al., 1999) ; MSCx (Agulnik et al., 1994a,b) ; MSCy (Agulnik et al., 1994a,b) ; Jumonji (Takeuchi et al., 1995) ; Retinoblastoma binding protein-2 (RBP2) (Fattaey et al., 1993) ; KIAA0224 (accession No: D87072); Regulator U.maydis 1 (RUM-1) (Quadbeck-Seeger et al., 2000) ; little imaginal discs (lid or Cg9088) (Gildea et al., 2000) ; retinoblastoma binding protein 2 related protein (RBP2RP) (accession No: T48727); ZK594.3 (Anonymous, 1998) . pattern of expression could also be seen at the protein level (Fig. 3b) . Plu-1, therefore, may play a role during normal MG development in the adult. The human PLU-1 gene was first cloned as a gene which was down regulated by inhibiting signalling from the c-erbB2 receptor (Lu et al., 1999) . We, therefore, examined expression of Plu-1 in transplantable tumours originating from a colony of BALB/c c-neu transgenic mice (Thomas et al., 1996) and found as expected high Plu-1 expression at both the protein (Fig. 3b ) and mRNA level (Fig. 3cH-K ),
Plu-1 expression in mouse embryo
The novel PLU domain binds two transcription factors, namely paired box 9 (PAX9) and a forkhead protein, BF-1 (Nornes et al., 1996; Rodriguez et al., 2001 ; K. Tan, A.T. Shaw, P. Freemont, personal communication). Although the expression of Pax9 and Bf-1 in adult tissues is highly restricted (Hatini et al., 1994; Murphy et al., 1994; Neubuser et al., 1995; Peters et al., 1997) , in the embryo, Pax9 has been shown to play an important role in the development of cranio-facial structures, teeth and limbs, and Bf-1 is crucial for the development of the brain (Hebert and McConnell, 2000; Huh et al., 1999; Peters et al., 1998a Peters et al., ,b, 1999 . We, therefore, investigated whether the profile of expression of Plu-1 in the mouse embryo overlaps the expression of these two transcription factors.
Dot blot analysis of mRNA extracted from whole embryos showed a temporally proportionally similar expression pattern with all three genes showing maximum expression at day 11 (Fig. 2B ). Whole mount in situ hybridisation was carried out on day 12.5-15.5 embryos and radioactive in situ hybridisa- tion analysis was carried out on sagittal sections of 14.5 day embryos (Figs. 4 and 5). Expression of Plu-1 correlates strongly with the development of organs where mesenchymal/epithelial interactions are known to be important including the mammary gland (Fig. 3cD, E) , teeth (Fig. 5B, C) , whisker follicles (Figs. 4G and 5A) and limbs (Fig. 4A) . Indeed a very distinct expression pattern was observed in the limbs with a very weak Plu-1 expression in the E12.5 hindlimb (Fig. 4A) . This increased to E14.5 where the expression was intense in the foot-plates, while at E15.5 the expression had weakened and become restricted to the areas between the tarsal and metatarsal areas (Fig. 4A ). This expression pattern is overlapping with the Pax9 expression in the limbs where Pax9 deficiency induces abnormalities (see Table 1 and Neubuser et al., 1995; Peters et al., 1998b) .
In Pax9 knock out mice, tooth development is arrested at E13.5 at the tooth bud stage, indicating a critical role for Pax9 in the early mesenchyme signalling (Keranen et al., 1999; Peters et al., 1998a) . Plu-1 is also highly expressed in the mesenchyme of the developing tooth as well as in the enamel knot (Fig. 5B ) (a layer of epithelial cells that works as a signalling centre directing further tooth development Fig. 5C) ). In common with Pax9, Plu-1 is well expressed in thymus (Fig. 5F) , tongue (not shown), and the eustachian tube (not shown). In the vertebral column at E13.5, Plu-1 expression is high in the less developed tail region in the condensed anlagen for the intervertebral disc (Fig. 4B) . In the thoracic region of the E14.5, where the vertebral column is more developed, the Plu-1 expression is restricted to the intervertebral discs (Fig. 5E Expression of Plu-1 in (C) day 12.5 embryo (lateral view) (D) frontal view, (E) day 13.5 lateral view. (F) Plu-1 is expressed in the telencephalic vesicle from day 12.5 -(tv C,D,E), in the stomach at day 14.5 pc (st F), and in the whisker follicles at day 15.5 pc (wG). Abbreviations: s, shoulder region; fl, forelimb; rg, dorsal root ganglion; oe, olfactory epithelium; fi, fibula; ti, tibia; st, stomach; w, whisker follicles. Scale bar ¼ 1 mm. and this is comparable to what was previously found for Pax9 (Neubuser et al., 1995; .
Throughout embryogenesis high Plu-1 expression is seen in the telencephalic vesicle as illustrated in Fig. 4C -E and G, from E12.5 to E15.5. Sagittal section through E14.5 revealed that Plu-1 mRNA is highly expressed in the telecephalic vesicle in the ganglionic eminence and telencephalon, and some expression is seen in the choroid plexus (Fig.  5H ). This expression pattern of Plu-1 correlates with the expression of Bf-1 in the telencephalic vesicle and Bf-1 knock out mice die at birth having a dramatic reduction in the size of the cerebral hemisphere (see Table 1 and Xuan et al., 1995) . Plu-1 also appears to be expressed in the developing eye. In the sagittal section of the eye at E14.5 (Fig.  5G) , Plu-1 is expressed throughout the retinal neuro-epithelium, with the highest expression being seen in the dorsal neural retina and some expression seen in the lens and in the optic nerve. Moreover, the eyes of Bf-1 knock out mice have dorsal-ventral patterning defects and posterior parts of the eye not expressing Bf-1 in the embryo are also affected. As . In situ hybridisation of Plu-1 expression in mouse embryos. Paired bright field (capital letters) and dark field photomicrographs (lower case letters) of Sagittal sections of day 14.5 pc mouse embryos hybridised with a Plu-1 antisense riboprobe. Abbreviations: W, whisker follicles; dm, dental mesenchyme; ek, enamel knot; t, tooth; th, thymus gland; e, oesophagus; iv, intervertebral disc; nr, neural retina; on, optic nerve; lf, lens fibres; tn, telencephalon; ge, ganglionic eminence; cp, choroid plexus; lv, lateral ventricle; oe, olfactory epithelium; cb, cerebellar primodium; fv, fourth ventricle; tg, trigeminal ganglion; rg, dorsal root ganglion of C2-C5; v, inferior ganglion of vagus X nerve; vt, vagus X trunk. Scale bar ¼ 100 mm.
shown in Fig. 4E high Plu-1 expression is observed from E13.5 in the olfactory epithelium and this expression decreases after E14.5 (Fig. 5J) and is low at E15.5 (Fig.  4G ) overlapping with Bf-1 expression in the olfactory epithelium (Hebert and McConnell, 2000) . Additionally, Plu-1 is also expressed in structures which develop from the neural crest including the neuroepithelium of the cerebellum (Fig. 5I) , the trigeminal ganglia (Fig. 5K) , the dorsal root ganglia (Fig. 5D ) and the inferior ganglion of the vagus nerve (Fig. 5L) . Finally, high Plu-1 expression was observed in the stomach at E14.5 (Fig. 4F) .
The above results demonstrate overlapping expression patterns of Plu-1 with Bf-1 and Pax9 in mouse embryonic development. This observation together with the demonstrated in vivo interaction between the human PLU-1 and BF-1/PAX9 suggest the possibility of functional interactions between PLU-1/Plu-1 and these factors during embryonic development. The similarity in structure and expression, in normal adult tissues, of the human and mouse PLU-1/Plu-1 genes suggest a strong conservation of function. It will, therefore, now be possible to analyse the functions of the proteins not only as transcriptional regulators in somatic cells, but also in embryonic and mammary gland development as well as during meiosis in testis. Moreover, the high expression of Plu-1 in mouse breast cancers should allow an in vivo analysis of the role of Plu-1 in this type of cancer.
Materials and methods
2.1. Cloning of the full-length mouse Plu-1 cDNA 3 0 and 5 0 mouse Plu-1 EST sequences were identified by BLAST searches against the human PLU-1 cDNA sequence (Lu et al., 1999) (Hatini et al., 1994; Hebert and McConnell, 2000; Huh et al., 1999; Marcus et al., 1999; Xuan et al., 1995) . References for PAX9 (Neubuser et al., 1995; Peters et al., 1998a,b; Keranen et al., 1999) .
b Data not shown.
was cloned into the pCR 2.1 vector using the TA cloning system (Invitrogen). Sequencing in both directions was performed using an ABI PRISM 377 DNA sequencer, Perkin-Elmer. For isolation of the 3 0 untranslated region 3 0 rapid amplification of cDNA ends (RACE) was performed using the SMART RACE cDNA Amplification kit from Clontech. The primers mPLU4500s (5 0 -GGTC-TGTTGGTGTCTCTCCAGAGAT-3 0 and mPLU5000s (5 0 -CGGCTTAAGAGTCCAACTCAGTTTCAGA-3 0 ) were generated further downstream to search for additional 3 0 ends. The SMART RACE fragments were cloned into pCR2.1 giving two products of 729 and 1200 bp with a poly(A) tail. The transcription start site was established by SMART RACE using the mPLU5 
RNA analysis
The blots were hybridized with the following probes: Plu-1 cDNA probe covering from 3.9 to 4.7 kb (mPLU-probe-this region at the 3 0 end of the Plu-1 mRNA showed minimal homology to other mouse genes), BF-1 probe covered from 1230 to 2300 bp and the PAX9 probe covered from 366 to 900 bp of the respective cDNAs, ubiquitin. The blots were hybridised under standard conditions.
Western blots
Protein lysates and Western blotting with a rabbit polyclonal antibody shown to specifically react with PLU-1 and Plu1 was performed as described (Barrett et al., 2002) .
In situ hybridization of mouse tissues and embryos
For specific localization of Plu-1 mRNA by in situ hybridisation, an antisense riboprobe synthesized from the Plu-1 probe (shown by northern blot to be specific for Plu-1 mRNA (Fig. 3) was prepared. The methods were as described by Poulsom et al. (1998) . The whole mount in situ hybridisation protocol was based on previously described methods (Revest et al., 2001 ). An antisense digoxigenin-labelled probe with the same sequence as used in northern blotting was synthesised from mouse Plu-1 cDNA.
